Chinnala Balaramulu

Chinnala Balaramulu

Active Director Director DIN 07024370
DIN 07024370 First appointment Dec 2014 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Chinnala Balaramulu

Data last updated:

Chinnala Balaramulu is a Director at Lorven Medi Life Sciences Private Limited (since 2014). The company operates in Chemicals.

DIN 07024370
Primary Designation Director
Industry Chemicals
First Appointment 01 Dec 2014
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Dec 20142014Under Process Of Striking Off

Directorship timeline

Open interactive timeline →
Lorven Medi Life Sciences Private Limited
Premium access

Shareholding and investment profile for Chinnala Balaramulu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chinnala Balaramulu

Chinnala Balaramulu currently holds 1 directorship: Lorven Medi Life Sciences Private Limited (Director, since 01 Dec 2014).

Chinnala Balaramulu was first appointed on 01 Dec 2014 as Director at Lorven Medi Life Sciences Private Limited.

The current boards of Chinnala Balaramulu's companies include Ramanaiah Madupaduga (Lorven Medi Life Sciences Private Limited), Srinivasa Rao Ande (Lorven Medi Life Sciences Private Limited), Sudhakar Sandela (Lorven Medi Life Sciences Private Limited), Varun Vihar Madupaduga (Lorven Medi Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available